Medical DevicesMedical InnovationsTechnology

Clinical and Technology Focus of New Medtech Startups

PatrickDriscoll
3 Min Read

Since January 2011, a total of 245 new medtech companies have been founded and added to the Medtech Startups Database from MedMarket Diligence. These are companies that are either device-based or based on other technologies that are directly competitive with, or complementary to, medical devices, inclusive of medical device implants, med/surg instruments or equipment, drug/device or biotech/device hybrids, bioresorable implants/devices and other similar technologies.

Since January 2011, a total of 245 new medtech companies have been founded and added to the Medtech Startups Database from MedMarket Diligence. These are companies that are either device-based or based on other technologies that are directly competitive with, or complementary to, medical devices, inclusive of medical device implants, med/surg instruments or equipment, drug/device or biotech/device hybrids, bioresorable implants/devices and other similar technologies. The companies excluded from this are those that are developign pure pharmaceutical products with no direct competitive/complementary role with medical devices or hybrids of info technology (e.g., smart-phone) piggybacked on existing medical devices.

The companies represented here cover a surprising range of innovations and clinical applications. They have been identified based on recently issued patents, patent applications, corporate filings and a litany of press releases, social media sources, and other data sources. As we identify the companies during this process, we categorize them into a number of clinical/technology categories, with multiple categories possible (e.g., minimally invasive plus cardio therapeutics, or diagnostic plus oncology, and others). Below is illustrated, in descending order, the clinical/technology categories of the companies founded since January 2011:

Screen Shot 2014-03-22 at 1.08.50 PM

More Read

Nanomedicine Attacks Bacteria Where Antibiotics Cannot

Bioengineered Skin & Skin Substitutes in Wound Care
The Outreach Mindset: How Doing Crisis Care Improves Medical Practice
Medical Megatrends – Stem Cells – Part II of III
Sutures, Staples and Other Fading Technologies

Source: Medtech Startups Database; MedMarket Diligence, LLC

Clearly, the great majority of medical technology startup companies is focused on surgical and/or cardio therapeutics and/or minimally invasive and/or orthomusculoskeletal applications, areas that have historically and persistently represented the dominant thrust of medtech innovation.

Another way to view these companies is a “word cloud” compiled from each company’s product/technology descriptions, with the most frequently occurring words in the descriptions being represented in larger type face in the graphic:

Source: Medtech Startups Database; MedMarket Diligence, LLC

Share This Article
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version